Prudential Financial’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $480K | Sell |
37,995
-2,020
| -5% | -$27.1K | ﹤0.01% | 1879 |
|
|
2025
Q4 | $631K | Buy |
+40,015
| New | +$508K | ﹤0.01% | 1759 |
|
|
2025
Q1 | – | Sell |
-60,364
| Closed | -$347K | – | 2317 |
|
|
2024
Q4 | $347K | Sell |
60,364
-96,700
| -62% | -$927K | ﹤0.01% | 1952 |
|
|
2024
Q3 | $1.63M | Hold |
157,064
| – | – | ﹤0.01% | 1606 |
|
|
2024
Q2 | $2.04M | Sell |
157,064
-15,200
| -9% | -$205K | ﹤0.01% | 1424 |
|
|
2024
Q1 | $3.01M | Sell |
172,264
-21,300
| -11% | -$282K | ﹤0.01% | 1213 |
|
|
2023
Q4 | $1.82M | Buy |
193,564
+13,500
| +7% | +$126K | ﹤0.01% | 1493 |
|
|
2023
Q3 | $2.01M | Buy |
180,064
+147,812
| +458% | +$2.38M | ﹤0.01% | 1366 |
|
|
2023
Q2 | $690K | Sell |
32,252
-10,747
| -25% | -$317K | ﹤0.01% | 1985 |
|
|
2023
Q1 | $1.74M | Buy |
42,999
+23,250
| +118% | +$1.11M | ﹤0.01% | 1431 |
|
|
2022
Q4 | $919K | Hold |
19,749
| – | – | ﹤0.01% | 1749 |
|
|
2022
Q3 | $1.02M | Buy |
19,749
+860
| +5% | +$50.2K | ﹤0.01% | 1741 |
|
|
2022
Q2 | $893K | Sell |
18,889
-405
| -2% | -$22K | ﹤0.01% | 1850 |
|
|
2022
Q1 | $1.37M | Buy |
19,294
+139
| +0.7% | +$9.04K | ﹤0.01% | 1728 |
|
|
2021
Q4 | $1.43M | Sell |
19,155
-255
| -1% | -$20K | ﹤0.01% | 1702 |
|
|
2021
Q3 | $1.1M | Sell |
19,410
-130
| -0.7% | -$6.43K | ﹤0.01% | 1755 |
|
|
2021
Q2 | $860K | Sell |
19,540
-1,006
| -5% | -$49.3K | ﹤0.01% | 1902 |
|
|
2021
Q1 | $1.01M | Sell |
20,546
-363
| -2% | -$18.1K | ﹤0.01% | 1822 |
|
|
2020
Q4 | $880K | Sell |
20,909
-2,640
| -11% | -$116K | ﹤0.01% | 1813 |
|
|
2020
Q3 | $1.08M | Buy |
23,549
+2,247
| +11% | +$109K | ﹤0.01% | 1608 |
|
|
2020
Q2 | $1.07M | Sell |
21,302
-4,264
| -17% | -$221K | ﹤0.01% | 1613 |
|
|
2020
Q1 | $1.31M | Sell |
25,566
-50,141
| -66% | -$2.67M | ﹤0.01% | 1566 |
|
|
2019
Q4 | $4.68M | Buy |
75,707
+42,377
| +127% | +$2.63M | 0.01% | 1162 |
|
|
2019
Q3 | $2M | Sell |
33,330
-334
| -1% | -$24.8K | ﹤0.01% | 1581 |
|
|
2019
Q2 | $2.84M | Buy |
33,664
+650
| +2% | +$58.5K | ﹤0.01% | 1424 |
|
|
2019
Q1 | $3.15M | Sell |
33,014
-6,215
| -16% | -$558K | 0.01% | 1352 |
|
|
2018
Q4 | $2.78M | Sell |
39,229
-180,586
| -82% | -$13.8M | ﹤0.01% | 1357 |
|
|
2018
Q3 | $18.8M | Sell |
219,815
-82,772
| -27% | -$8.29M | 0.03% | 638 |
|
|
2018
Q2 | $35.1M | Buy |
302,587
+85,397
| +39% | +$8.52M | 0.05% | 419 |
|
|
2018
Q1 | $17.6M | Buy |
217,190
+124,458
| +134% | +$9.58M | 0.03% | 665 |
|
|
2017
Q4 | $5.44M | Buy |
92,732
+46,135
| +99% | +$2.31M | 0.01% | 1111 |
|
|
2017
Q3 | $2.18M | Buy |
46,597
+490
| +1% | +$19.7K | ﹤0.01% | 1547 |
|
|
2017
Q2 | $1.66M | Sell |
46,107
-23,564
| -34% | -$754K | ﹤0.01% | 1651 |
|
|
2017
Q1 | $2.15M | Buy |
69,671
+20,743
| +42% | +$646K | ﹤0.01% | 1535 |
|
|
2016
Q4 | $1.64M | Sell |
48,928
-32,476
| -40% | -$931K | ﹤0.01% | 1635 |
|
|
2016
Q3 | $2.17M | Buy |
81,404
+34,330
| +73% | +$797K | ﹤0.01% | 1470 |
|
|
2016
Q2 | $1.04M | Sell |
47,074
-1,640
| -3% | -$42.9K | ﹤0.01% | 1818 |
|
|
2016
Q1 | $1.43M | Buy |
48,714
+18,344
| +60% | +$511K | ﹤0.01% | 1689 |
|
|
2015
Q4 | $1M | Buy |
30,370
+600
| +2% | +$19.6K | ﹤0.01% | 1784 |
|
|
2015
Q3 | $1.08M | Sell |
29,770
-15,200
| -34% | -$653K | ﹤0.01% | 1725 |
|
|
2015
Q2 | $2.02M | Buy |
+44,970
| New | +$1.75M | ﹤0.01% | 1569 |
|
|
2014
Q4 | – | Sell |
-14,970
| Closed | -$592K | – | 2205 |
|
|
2014
Q3 | $592K | Buy |
+14,970
| New | +$597K | ﹤0.01% | 1877 |
|
|
2014
Q1 | – | Sell |
-15,070
| Closed | -$411K | – | 2268 |
|
|
2013
Q4 | $411K | Buy |
+15,070
| New | +$365K | ﹤0.01% | 2009 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Prudential Financial's ENTA Position: Q1 2026 in Review
Prudential Financial reduced its Enanta Pharmaceuticals (ENTA) stake by 5% in Q1 2026, selling an estimated $27.1K and leaving 37,995 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #1879.
Prudential Financial first reported a position in ENTA in Q4 2013 and has held it in 43 quarters since. The position peaked at $35.1M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Prudential Financial held 37,995 shares of Enanta Pharmaceuticals worth $480K as of Q1 2026.
- Prudential Financial sold 2,020 Enanta Pharmaceuticals shares in Q1 2026, an estimated $27.1K.
- Enanta Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1879 holding.
- Prudential Financial first reported a position in Enanta Pharmaceuticals in Q4 2013 and has held it in 43 quarters since.
- Prudential Financial's Enanta Pharmaceuticals position peaked at $35.1M in Q2 2018.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.